Psimei welcomes collaborative or licensing opportunities with institutions, companies and academic research groups that have innovative products / technology, particularly early stage projects with potential applications in the treatment of cancer. Psimei is interested in products, product candidates or technology, which meet most of the criteria outlined below.

Technology profile:

• Is Innovative
• Targets a significant unmet medical need
• Is based on scientifically robust principles
• Has strong intellectual property protection

Psimei will also consider early stage innovative product/technology particularly in early research.

Advantages of Psimei as a partner

• Entrepreneurial empowering culture - we get things done
• A focused innovative integrated pharmaceutical approach
• Expertise in drug discovery, preclinical and drug development
• Speed in taking candidates into drug development
• Proven development infrastructure
• Experienced team with strong biotechnology and commercial knowledge base

If you have a truly innovative technology or product and really want to unlock its real therapeutic and commercial potential please contact us at enquiries@psimei.co.uk.